Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Spinal Cord Stimulators Market Outlook 2023 to 2033

The spinal cord stimulators market size is estimated to register a revenue of US$ 5,441.4 million by 2033. Our healthcare experts opine that spinal cord stimulator suppliers can expect a promising CAGR of 7.2% through 2033, with a present valuation of US$ 2,702.7 million in 2023.

Spinal Cord Stimulators Market Trends

Clinical Studies to Enhance the Market Demand for Spinal Cord Stimulators

Key players are initiating clinical studies to further the market expansion. For instance, ANEUVO, a platform and therapy development firm, recently commenced the clinical study of the ExaStim TSS system, a wirelessly controlled neuromodulation system engineered for transcutaneous spinal cord stimulation (TSS). The study intends to research the safety and efficacy of ExaStim in combination with conventional rehabilitation therapy for patients with upper extremity paralysis.

TSS is an emerging neuromodulation therapy with the scope to assist individuals suffering from SCI to better their motor function. ExaStim therapy stimulates the spinal cord to modulate neural networks to improve motor function. Initial research suggests that non-invasive spinal stimulation may assist individuals with SCI in recovering lost motor function and improving their functional independence.

Recent Advances in Spinal Rehabilitation Technology

The market is observing significant advances in spinal rehabilitation therapy and technology. For instance, the American Congress of Rehabilitation Medicine (ACRM) conference in 2022 exhibited several new technologies and trends in spinal cord rehabilitation. These are expected to enhance the management of spinal cord injury (SCI).

One of the recent innovations includes neuromodulation devices. These involve the usage of electrodes on the brain, peripheral nerves, or the spinal cord. It functions by actively stimulating nerves to develop a natural biological response or by using targeted pharmaceutical agents in small doses straight to the site. The latest evidence has showcased that almost 50% of patients have stated enhanced pain management.

Attributes Details
Spinal Cord Stimulators Market Size, 2022 US$ 2,550.3 million
Spinal Cord Stimulators Market Size, 2023 US$ 2,702.7 million
Spinal Cord Stimulators Market Size, 2033 US$ 5,441.4 million
Value CAGR (2023 to 2033) 7.2%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Performance of Spinal Cord Stimulators Market Vs. Forecast Outlook

The spinal cord stimulators market is estimated to expand at a higher CAGR of 7.2% in the forecast period, in comparison to the 5.8% CAGR observed in the historical period.

Spinal Cord Stimulators Market Size (2018) US$ 2,037.50 million
Spinal Cord Stimulators Market Size (2022) US$ 2,550.3 million
Spinal Cord Stimulators Market (CAGR 2018 to 2022) 5.8%

According to the estimates by the National Spinal Cord Injury Statistical Center, chronic diseases have now doubled in the past few years. In the United States alone, 54 incidences of injuries in every million get listed under SCI owing to surged injuries and traumas associated with spinal procedures and treatments. The spinal cord stimulator industry is expected to swell due to rising cases of chronic diseases in the upcoming years.

The industry is projected to widen as awareness about the advantages of these technologies to alleviate pain becomes widespread. The schemes and policies offered by the government to profit the elderly population and underprivileged people by getting treated at reasonable costs are significant factors leading to market expansion.

Comparative Study Report of Adjacent Spinal Cord Stimulators Markets

Increasing cases of spinal cord injuries are giving way to several treatment devices, like non-fusion spinal devices, spinal cord stimulators, neurostimulators, etc. The demand outlook for non-fusion spinal devices is driven by the surging aging population and increasing preference for minimally invasive surgery treatments.

In the following table, FMI analysts analyze the spinal cord stimulators market in comparison to the functional electrical stimulation market and neurostimulation market. As per the recent projections, the neurostimulation market is expected to expand at a greater CAGR of 11.5% through 2033. In terms of revenue, the neurostimulation market is expected to be worth US$ 7.22 billion in 2023, significantly greater than the other two compared markets.

Spinal Cord Stimulators Market

Attributes Spinal Cord Stimulators Market
CAGR (2023 to 2033) 7.2%
Market Value (2023) US$ 2,702.7 million
Growth Factors
  • Increasing clinical trials for emerging technologies
  • Heightened awareness among patients and physicians
Future Opportunities Surging return on investment in recent technologies is expected to increase the scope of SCS devices.
Market Trends Emergence of the latest spinal cord stimulation technologies

Functional Electrical Stimulation Market

Attributes Functional Electrical Stimulation Industry
CAGR (2023 to 2033) 4.1%
Market Value (2023) US$ 620.9 million
Growth Factors
  • Surging prevalence of SCIs
  • Growing awareness about therapeutic benefits and enhancements in medical technology
Future Opportunities Growing importance of pain management devices in several areas of medicine
Market Trends Surging technological innovations

Neurostimulation Market

Attributes Neurostimulation Market
CAGR (2023 to 2033) 11.5%
Market Value (2023) US$ 7.22 billion
Growth Factors
  • Increasing preference for neurostimulation devices that can be used at home
  • Surging adoption of advanced technologies for responsive neurostimulation
Future Opportunities Increasing adoption of brain neurostimulation devices for an effective treatment of age-related and neurotic symptoms
Market Trends The development of implantable neurostimulation devices drives the growth of the global neurostimulation market.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

Country/ Region Value Share (2022)
North America 75.2%
Europe 14.8%
The United States 73.1%
Germany 2.3%
Japan 4.9%

Financial Support from Medicare for SCS Operations is Fueling the Market in the United States

The spinal cord stimulators are instrumental in treating chronic neuropathic pain refractory. This treatment option is used when intractable chronic pain has not improved with conventional treatment modalities. Several SCS/neuromodulation recipients include women of childbearing age who may become pregnant. As per the latest market estimates, the North America market for spinal cord stimulators holds the maximum market share of around 75.2%.

The United States spinal cord stimulators market is expected to acquire a market value of about 73.1% in 2022. The market development can be attributed to the utilization patterns that show a drastic surge in spinal cord stimulation trials. Moreover, due to ongoing research and study, the medical literature exhibits the efficacy of spinal cord stimulation in alleviating chronic pain and improving quality of life and cost-utility.

The market in the United States is also thriving due to Medicare-approved SCS operations. From 2000 to 2019, there were 9,92,372 Medicare-approved percutaneous cord stimulator operations. Total open spinal cord stimulator operations, in this duration that were Medicare-approved included somewhere around 99,736. In 2019, Medicare paid US$ 1.02 billion and US$ 145 million in reimbursement to physicians for percutaneous spinal cord stimulator and open spinal cord stimulator operations, respectively.

Soaring Cases of Failed Back Surgery Syndrome to Augment the European Market

The Europe market is expected to acquire about 14.8% in 2023. The region is led by Germany, which has a market contribution of 2.3% on a global scale. The regional market is catalyzed by the increasing cases of failed back surgery syndrome, also known as postlaminectomy syndrome (PLS). The treatment of this disorder entails the deployment of spinal cord stimulators. With the advent of the latest technologies, the demand for SCS devices has dramatically surged to alleviate axial pain effectively. Rising demand for industry-sponsored trials for improved outcomes is expected to consolidate the market.

The United Kingdom market is expected to thrive at a CAGR of 6.9% through 2033. Throughout the forecast period, the soaring presence of highly qualified healthcare professionals, surging awareness about SCS, and fueling healthcare funding are expected to advance the market growth.

Emergence of iPS Cells Technique to Fuel Sales of Spinal Cord Stimulators in Japan

The Japan market for spinal cord stimulators is expected to acquire a market share of around 4.9% in 2023. The market is experiencing a surge in patients suffering from neuropathic pain and choosing spinal procedures due to injuries and trauma. Moreover, Japan's health ministry has permitted induced pluripotent stem cells (iPS) to treat spinal cord injuries. iPS is being studied at Keio University in Japan, and it is considered one of the most significant treatment plans in regenerative medicine techniques.

The technique of iPS cells has escalated the expectations of mobility and function of paralyzed muscles. Consequently, this fueled the demand for the growth of spinal cord stimulators.

India and China to be Notable Markets for Spinal Cord Stimulators in Asia Pacific

The Asia Pacific spinal cord stimulators market is expected to expand at a notable CAGR. The region is being supported by the growth in the emerging economies of the continent, particularly China and India, which show growth rates of 5.8% and 5.5% CAGRs, respectively. Since chronic pain is a critical social burden in Asian countries, the market for spinal cord stimulators is surging at an elevated rate. This is because spinal cord stimulation (SCS) is a promising treatment for refractory pain.

Analysts at FMI have predicted positive future trends for the uptake of spinal cord stimulators by hospitals, clinics, and ambulatory surgical centers. As research in this field is gaining high traction, and different regional organizations are coming forward to provide financial support for the said research, the market scope is expected to amplify over the forecast period.

China is expected to facilitate the establishment of novel indications for SCS, considering that at least one of their active trials is feasibility research of epidural stimulation in patients suffering from disorders of consciousness.

High Return on Investment of New Treatment Plans to Spur the Australia Market

The spinal cord stimulators market in Australia is expected to expand at a CAGR of 6.9% through 2033. The increasing commitment from the public, as well as the private sector, is critical in obtaining treatments from bench to bedside. Researchers have predicted the requirement of US$ 10 to 20 million in research investment to boost the adoption rate of spinal cord stimulation by all Australians suffering from spinal cord injury (SCI). In Australia, around 20,800 Australians have been diagnosed with SCI as of 2020, boosting the uptake of treatment options.

Despite the high cost of delivery of treatment plans, their return on investment is quite high. For instance, the new spinal cord stimulation treatment, which requires US$ 20 million of investment, can gain a cost saving of US$ 1.3 billion, thus resulting in a benefit-cost ratio of 1.96.

Category-wise Insights

Rechargeable Stimulator Devices Wireless Technology to Gain Larger Market Share

The rechargeable stimulator devices are gaining high traction. As per the analysts at FMI, the segment is expected to occupy a market share of around 67.7% in 2023. Factors like adaptability, affordability, and ability to control pain via wireless remote procedures are attributed to the surging adoption of these devices.

Top Segment Rechargeable Stimulator Devices
Market Share in 2023 67.7%

Rechargeable stimulator devices facilitate curbing neuropathic pain by moderately electrically stimulating the spinal cord near pain points. Additionally, the battery of these devices is easy to replace.

The new product launches by prominent firms and the surge in patients with neuropathic and chronic pain are fueling the market growth. As reported by the NIH report on rechargeable and non-rechargeable systems in 2021, the median longevity of rechargeable devices was relatively greater than that of non-rechargeable devices purchased at similar costs.

Failed Back Surgery Syndrome to Surmount the Marketplace

Failed back surgery syndrome is expected to account for around 65.6% of the global market share in 2023. As per the research undertaken in North America, Latin America, and Europe, 44.6% cases of overall SCI cases were of failed back surgery syndrome (FBSS).

Top Segment Failed Back Surgery Syndrome
Market Share in 2023 65.6%

Increasing advances in the spinal cord stimulation technique by the top investors are expected to lead the market growth. Increasing healthcare infrastructure and mounting healthcare funding are also driving the growth of this segment.

Surge in Minimally Invasive Surgeries Operated in ASCs

The ambulatory surgical centers (ASC) segment led the market by 59.1% market share. This segment has amassed significant revenue on account of cost-effective procedures and shorter stay periods.

Top Segment Ambulatory Surgical Centers
Market Share in 2023 59.1%

Apart from this, manufacturers educate citizens about the benefits of SCS devices, which also contributes to the increase in patients seeking diagnostic procedures to overcome any challenge later on. The surge in the minimally invasive surgeries operated in ASCs is also fueling the sales in ambulatory surgical centers.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Strategies Employed by Market Players

Key players in the market are going for M&A methods to gain a swift and low-risk entry in the global spinal cord stimulators market. M&A also helps widen the scope of the product portfolio. Additionally, active companies are emphasizing the research and development of new technologies to effectively manage pain. This creates a high preference for the leading players.

New Developments Taken Place in the Market

  • In March 2023, Nevro reported the United States-wide release of the HFX iQ spinal cord stimulation system. HFX iQ begins patients on the program for pain relief, based on Nevro’s HFX algorithm. The device combines clinical inputs and quality-of-life inputs to offer an individualized program setting for every patient.
  • In February 2023, ANEUVO introduced the United States study of ExaStim, which is a non-invasive spinal neuromodulation system, to assess its effectiveness and safety for paralysis owing to spinal cord injury.
  • In April 2023, Biotronik gained FDA permission for Prospera's spinal cord stimulation system. With this launch, the company aims to enhance patient care while lowering the burden on clinicians, patients, and caregivers.

Market Players:

  • Medtronic Public Limited Company
  • Boston Scientific Corp
  • St Jude Medical LLC and Nevro Corp
  • Nuvectra Corporation and Stimwave
  • Neurosigma Inc.
  • Synapse Biomedical Inc.
  • Abbott Laboratories
  • Beijing PINS Medical Co., Ltd
  • Cirtec Medical Corporation
  • Gimer Medical
  • Bluewind Medical
  • Bioinduction
  • Greatbatch, Inc.
  • Saluda Medical Pty Ltd.

Segments Covered in the Spinal Cord Stimulators Market Report

Products:

  • Rechargeable
  • Non-Rechargeable

Application:

  • Failed Back Surgery Syndrome
  • Complex Regional Pain Syndrome
  • Ischemic Limb pain
  • Others

End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

How Big is the Spinal Cord Stimulators Market?

The spinal cord stimulators market is worth US$ 2,702.7 million in 2023.

What is the Growth Potential of Spinal Cord Stimulators?

The market is expected to expand at a CAGR of 7.2% through 2033.

Which Country Leads the Spinal Cord Stimulators Market?

The United States leads the spinal cord stimulators market.

Which Product Type is Highly Preferred in the Market?

Rechargeable spinal cord stimulators are witnessing high preference by end users.

Who are the Competitors of Spinal Cord Stimulators?

Boston Scientific Corp, Greatbatch, Inc., and Saluda Medical Pty Ltd. are the key competitors of SCS.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Products

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Products, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Products, 2023 to 2033

        5.3.1. Rechargeable

        5.3.2. Non-Rechargeable

    5.4. Y-o-Y Growth Trend Analysis By Products, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Products, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Failed back Surgery Syndrome

        6.3.2. Complex Regional Pain Syndrome

        6.3.3. Ischemic Limb pain

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Ambulatory Surgical Centers

        7.3.3. Clinics

    7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Products

        9.2.3. By Application

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Products

        9.3.3. By Application

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Products

        10.2.3. By Application

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Products

        10.3.3. By Application

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Products

        11.2.3. By Application

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Products

        11.3.3. By Application

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Products

        12.2.3. By Application

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Products

        12.3.3. By Application

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Products

        13.2.3. By Application

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Products

        13.3.3. By Application

        13.3.4. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Products

        14.2.3. By Application

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Products

        14.3.3. By Application

        14.3.4. By End User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Products

        15.2.3. By Application

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Products

        15.3.3. By Application

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. U.S.

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Products

            16.1.2.2. By Application

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Products

            16.2.2.2. By Application

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Products

            16.3.2.2. By Application

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Products

            16.4.2.2. By Application

            16.4.2.3. By End User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Products

            16.5.2.2. By Application

            16.5.2.3. By End User

    16.6. U.K.

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Products

            16.6.2.2. By Application

            16.6.2.3. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Products

            16.7.2.2. By Application

            16.7.2.3. By End User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Products

            16.8.2.2. By Application

            16.8.2.3. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Products

            16.9.2.2. By Application

            16.9.2.3. By End User

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Products

            16.10.2.2. By Application

            16.10.2.3. By End User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Products

            16.11.2.2. By Application

            16.11.2.3. By End User

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Products

            16.12.2.2. By Application

            16.12.2.3. By End User

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Products

            16.13.2.2. By Application

            16.13.2.3. By End User

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Products

            16.14.2.2. By Application

            16.14.2.3. By End User

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Products

            16.15.2.2. By Application

            16.15.2.3. By End User

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Products

            16.16.2.2. By Application

            16.16.2.3. By End User

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Products

            16.17.2.2. By Application

            16.17.2.3. By End User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Products

            16.18.2.2. By Application

            16.18.2.3. By End User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Products

            16.19.2.2. By Application

            16.19.2.3. By End User

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Products

            16.20.2.2. By Application

            16.20.2.3. By End User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Products

            16.21.2.2. By Application

            16.21.2.3. By End User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Products

            16.22.2.2. By Application

            16.22.2.3. By End User

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Products

            16.23.2.2. By Application

            16.23.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Products

        17.3.3. By Application

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Medtronic Public Limited Company

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. Boston Scientific Corp

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. St Jude Medical LLC and Nevro Corp

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Nuvectra Corporation and Stimwave

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Neurosigma Inc.

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Synapse Biomedical Inc

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. Abbott Laboratories

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Beijing PINS Medical Co., Ltd

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Cirtec Medical Corporation

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. Gimer Medical

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

        18.1.11. Bluewind Medica

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

                18.1.11.5.2. Product Strategy

                18.1.11.5.3. Channel Strategy

        18.1.12. Bioinduction

            18.1.12.1. Overview

            18.1.12.2. Product Portfolio

            18.1.12.3. Profitability by Market Segments

            18.1.12.4. Sales Footprint

            18.1.12.5. Strategy Overview

                18.1.12.5.1. Marketing Strategy

                18.1.12.5.2. Product Strategy

                18.1.12.5.3. Channel Strategy

        18.1.13. Greatbatch, Inc

            18.1.13.1. Overview

            18.1.13.2. Product Portfolio

            18.1.13.3. Profitability by Market Segments

            18.1.13.4. Sales Footprint

            18.1.13.5. Strategy Overview

                18.1.13.5.1. Marketing Strategy

                18.1.13.5.2. Product Strategy

                18.1.13.5.3. Channel Strategy

        18.1.14. Saluda Medical Pty Ltd.

            18.1.14.1. Overview

            18.1.14.2. Product Portfolio

            18.1.14.3. Profitability by Market Segments

            18.1.14.4. Sales Footprint

            18.1.14.5. Strategy Overview

                18.1.14.5.1. Marketing Strategy

                18.1.14.5.2. Product Strategy

                18.1.14.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Disposable Spinal Instrument Market

Published : February 2024

Healthcare

Non Fusion Spinal Devices Market

Published : February 2023

Healthcare

Dynamic Spinal Tethering Systems Market

Published : July 2022

Healthcare

China Spinal Fusion Market

Published : June 2022

Explore Healthcare Insights

View Reports

Spinal Cord Stimulators Market